Загрузка...
Chimeric antigen receptors for the adoptive T cell therapy of hematologic malignancies
The genetic modification of autologous T cells with chimeric antigen receptors (CARs) represents a breakthrough for gene engineering as a cancer therapy for hematologic malignancies. By targeting the CD19 antigen, we have demonstrated robust and rapid anti-leukemia activity in patients with heavily...
Сохранить в:
| Опубликовано в: : | Int J Hematol |
|---|---|
| Главные авторы: | , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2013
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4684946/ https://ncbi.nlm.nih.gov/pubmed/24311149 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12185-013-1479-5 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|